Pharvision Advisers, LLC originally filed its 13F report for Q1 2026 on April 21, 2026. The filing was subsequently amended, with the latest update submitted on May 11, 2026. The portfolio totaled 325,717 reflecting a -99.84% change from the prior quarter, spanning 7 assets. The top 10 holdings comprised 100.0% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 3 new positions and 662 complete exits.
Items:
Total Value:
| Issuer Name | Class | Value | Shares | Option Type |
|---|
Yes. Pharvision Advisers originally filed on 04/21/2026 and subsequently submitted 1 amendment(s). The latest filing (13F-HR/A) was submitted on 05/11/2026.
In the Q1 2026 filing, Pharvision Advisers reported a managed portfolio value of 9.86 M, consisting of 97 individual positions.
Multiple filings indicate that Pharvision Advisers updated their Q1 2026 report. The initial filing was submitted on 04/21/2026, followed by amendments to correct data or disclose previously confidential holdings.
This page displays the raw filing documents. To see which stocks Pharvision Advisers bought or sold during Q1 2026, please visit Pharvision Advisers's Portfolio Analysis page.